Tumor Marker

Tumor markers are substances—usually proteins—made by cancer cells or by your body in response to cancer. They can be measured in bloodurine, or tissue. Tumor markers are not perfect: some people with cancer have normal levels, and many noncancer conditions can raise them. For most cancers, tumor markers are not used to screen people without symptoms. Instead, doctors use them to support a diagnosis, to help estimate risk when a mass is already found, and to monitor how ... See more

  • Page
  • 1
  • of
  • 3
  • Total Rows
  • 60
Name Matches
Blood, Varied, Serum
Phlebotomist

Serum
Phlebotomist

 The CA-1 Cancer Screening - Women panel is specifically designed as an initial screening tool for the early detection of various cancers that commonly affect women. This panel combines several tumor markers and protein measurements, each carefully selected for their relevance in detecting specific cancer types. The panel is an important resource for those who are at increased risk of cancer, either due to family history, genetic predisposition, or other risk factors. By measuring specific biomarkers, this panel helps in identifying cancer at an early stage, where treatment can be more effective and less invasive.
Serum
Phlebotomist

Serum, Blood
Phlebotomist

 The CA-2 Cancer Screening - Women panel is a specialized diagnostic tool designed for the early detection and ongoing monitoring of various cancers specifically in women. It expands upon basic cancer screening by including additional markers that provide a wider range of detection and insight into different types of cancers. This panel is particularly valuable for women who are at increased risk due to genetic predispositions, family history, or environmental factors. It helps in the early identification of cancer, potentially improving the effectiveness of treatments and increasing the chances of successful outcomes.
Serum, Blood
Phlebotomist

Varied, Blood, Serum
Phlebotomist

 The CA-3 Cancer Screening - Women panel is an extensive diagnostic tool designed for an in-depth analysis of various cancer-related markers, specifically tailored for women. This advanced screening panel integrates additional markers to enhance the detection and monitoring capabilities for a broad spectrum of cancers. It is instrumental in providing a comprehensive overview of a woman's cancer risk profile, facilitating early intervention, and guiding effective treatment strategies.
Blood, Varied, Serum
Phlebotomist

Blood, Varied, Serum
Phlebotomist

 The CA-4 Cancer Screening - Women panel is the most comprehensive diagnostic tool available for assessing cancer risk and monitoring the health of women potentially at high risk for various cancers. It encompasses an extensive range of biomarkers, each specifically chosen to detect early signs of cancer and monitor treatment progress or recurrence. This panel is essential for women with a significant family history of cancer, known genetic predispositions, or those who have had previous cancer diagnoses and need close surveillance.
Varied, Serum, Blood
Phlebotomist

Serum
Phlebotomist

Varied, Serum
Phlebotomist

Serum, Varied
Phlebotomist

Serum, Varied
Phlebotomist

Serum
Phlebotomist

Varied, Serum
Phlebotomist

Varied, Serum
Phlebotomist

Serum, Varied
Phlebotomist

 The Cancer Screening - Men panel is a comprehensive diagnostic tool designed to detect early signs of various cancers in men. This panel includes a series of tests that measure specific biomarkers associated with different types of cancer. By assessing these biomarkers, healthcare providers can identify the presence of cancer at an early stage, when treatment is often more effective. This panel is crucial for men who are at higher risk of developing cancer due to factors such as age, family history, or lifestyle.
Serum
Phlebotomist

The Cancer Screening - Women Panel is a comprehensive set of blood tests designed to detect various cancer markers in women. This panel assesses levels of specific proteins that can be elevated in the presence of certain types of cancer. By measuring these markers, healthcare providers can gain valuable insights into a patient's risk of having cancer, monitor the progression of the disease, and evaluate the effectiveness of treatment.
Serum
Phlebotomist

The 5-HIAA 24 Hour Urine Test evaluates serotonin metabolism by measuring 5-hydroxyindoleacetic acid excreted over 24 hours. Elevated levels are often linked to carcinoid tumors or neuroendocrine disease, while low levels may reflect impaired serotonin activity. This test provides insight into endocrine health, hormone regulation, and systemic conditions affecting metabolic balance.

Urine
Phlebotomist

The Alpha-1 Antitrypsin Random Feces Test measures levels of alpha-1 antitrypsin, a protein that normally remains in the bloodstream. Elevated amounts in stool suggest protein-losing enteropathy, intestinal inflammation, or gastrointestinal conditions that impair absorption. By evaluating protein loss through the digestive tract, this test helps assess intestinal integrity and overall digestive health.

Varied
Phlebotomist
Also Known As: Alpha-1 Antitrypsin Test, A1AT Test, AAT Test, Alpha-1 Antitrypsin Feces Test

The Alpha-1 Antitrypsin 24 Hour Feces Test measures levels of alpha-1 antitrypsin in stool to evaluate protein loss through the gastrointestinal tract. Elevated results indicate protein-losing enteropathy, a condition where proteins leak into the intestines. This test provides valuable insight into unexplained edema, malnutrition, or chronic diarrhea, helping clinicians assess digestive health and guide evaluation of protein metabolism.

Stool/Feces
Phlebotomist
Also Known As: Alpha-1 Antitrypsin Test, A1AT Test, AAT Test, Alpha-1 Antitrypsin Feces Test

The Alpha-1-Antitrypsin Quantitative Test measures levels of alpha-1-antitrypsin (AAT), a protein that protects the lungs and liver from damage. Low levels may indicate alpha-1-antitrypsin deficiency, a genetic disorder linked to emphysema, COPD, and liver disease. Doctors use this test to investigate unexplained lung or liver problems, confirm hereditary AAT deficiency, and guide treatment or monitoring strategies for long-term health management.

Serum
Phlebotomist
Also Known As: Alpha-1 Antitrypsin Test, A1AT Test, AAT Test, Alpha-1 Antitrypsin Serum Test

The Alpha-Fetoprotein (AFP) and AFP-L3 Test measures total AFP and the AFP-L3 fraction, which is more specific for liver cancer risk. Elevated AFP may indicate liver disease, germ cell tumors, or hepatitis, while AFP-L3 is strongly associated with hepatocellular carcinoma (HCC). Doctors order this test to assess liver function, screen high-risk patients, and monitor cancer treatment. Results provide critical insight into liver health and cancer detection.

Serum
Phlebotomist
Also Known As: AFP Test, Total AFP Test, Alpha-Fetoprotein Tumor Markers, Alpha-Fetoprotein Test

The Amylase Test measures amylase enzyme levels in blood to evaluate pancreatic and digestive health. Elevated amylase may indicate pancreatitis, gallbladder disease, intestinal blockage, or salivary gland disorders, while low levels may suggest chronic pancreatitis or liver damage. Doctors order this test to investigate abdominal pain, nausea, or fever. Results provide vital insight into pancreatic function, digestive disorders, and overall metabolic health.

Serum
Phlebotomist
Also Known As: Amy Test

Tumor and Cancer Markers  

Cancer is an ailment in which specific cells grow abnormally or uncontrollably and spread to other cells or parts of the human body. The thing about cancerous cells is that they don't follow the normal process that healthy cells in the body do. Normal cells grow and multiply (through cell division) to form new cells required by the body. When cells become damaged or grow old, they die and get replaced by new ones. However, that's not the case with cancerous cells, as they continue to grow and multiply even when they aren't supposed to. 

When cancerous cells multiply, they form cell masses known as tumors, which grow big enough to interfere with normal body functions and damage healthy tissues. However, it's worth noting that not all types of cancers form tumors (for example, leukemia), and not all tumors found in the body are malignant. Others can be benign, meaning they are non-spreading and non-cancerous.  

... See more